Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy
Author:
Affiliation:
1. Seattle Children’s Research Institute, Seattle, WA;
2. Department of Pediatrics and
3. Department of Neurology, University of Washington, Seattle, WA; and
4. Clinical Statistics Group, Juno Therapeutics, Inc., Seattle, WA
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/134/24/2149/1547430/bloodbld2019001463.pdf
Reference28 articles.
1. Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults;Gardner;Blood,2017
2. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N Engl J Med,2018
3. Chimeric antigen receptor T cells in refractory B-cell lymphomas;Schuster;N Engl J Med,2017
4. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma;Neelapu;N Engl J Med,2017
5. Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor-modified T-cell therapy;Hay;Blood,2017
Cited by 189 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Tumor-associated antigen targets for novel immune-based strategies in prostate cancer;Journal of Translational Genetics and Genomics;2024-02-06
2. Current advances in experimental and computational approaches to enhance CAR T cell manufacturing protocols and improve clinical efficacy;Frontiers in Molecular Medicine;2024-02-01
3. INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies—Established Findings and Future Priorities;Transplantation and Cellular Therapy;2024-02
4. Cytokine Release Syndrome Following CD19 Directed Chimeric Antigen Receptor T-Cell Therapy;Manual of Hematopoietic Cell Transplantation and Cellular Therapies;2024
5. INSPIRED Symposium Part 3: Prevention and Management of Pediatric Chimeric Antigen Receptor T Cell-Associated Emergent Toxicities;Transplantation and Cellular Therapy;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3